Angelika Florvaag, kvalitetssjef i Hofseth Biocare ASA, har i dag 30.12.2016 kjøpt 10.000 aksjer til snittkurs 1,20 pr aksje i Hofseth BioCare ASA. Etter dette har Angelika Florvaag 10.000 aksjer i Hofseth BioCare ASA, tilsvarende 0,004 % av aksjene i Hofseth BioCare ASA.
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12
Recommended Reading
-
Reference is made to the stock exchange announcement by Hofseth BioCare ASA (the "Company") from 28 June 2026 regarding the successful placing of a private placement of new Ordinary Shares in the...
Read More -
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") has today, 17 September 2026, bought 2,500,000 shares in HBC in an off-market transaction at an...
Read More